# Lilly's Retatrutide Trounces Ozempic In Head-To-Head Study

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-29 19:29 UTC · Category: Business · Sources: 1 · Current Velocity: 0.25

## Key People, Organizations & Locations
Study, Ozempic, Lilly, Retatrutide, Head-to-head, Trounces

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Scripps News | Could this drug be the next Ozempic? Lilly reports dramatic trial results | 2026-10-28 21:12 | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxOeDBJdzNfYUtWeFB4N0RhOVBFQUlsTWlpRG83R0cwTFFXaFVVRUx2NnVoNkVjbF9Oby11TlZWaW9ncEtmc2d3Tk5sTEc4blJvME9uXzFYeE83bVo3dnpMMkNaMllyRmxYWmJGLWU5VVNfWmJMdUpRZERMMmROckVib0ZYc3pPcHkxY0lvX0RiZmxoTkZqRGZtdmhyZjBaTjVmSG82Z1o4M0tRdkI5SzA4RWNfYnBBNlU?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-29/lilly-s-retatrutide-trounces-ozempic-in-head-to-head-study*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*